|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home >> Country >> India >> Company
|
Y/E Mar, Rs mn | FY11 | FY12 | FY13 | FY14E | FY15E | Price | | | | | 1697 | Target | | | | | 1540 | Reco | | | | | NEU | Net Sales | 22,206 | 26,239 | 30,841 | 35,449 | 40,023 | Growth (%) | | 18 | 18 | 15 | 13 | EBIDTA | 5,147 | 5,785 | 6,568 | 6,640 | 7,982 | EBITDA Margin | | 22 | 21 | 19 | 20 | Net Profit | 4,026 | 4,464 | 4,967 | 4,920 | 5,509 | Growth (%) | | 11 | 11 | -1 | 12 | EPS, Rs | 30 | 33 | 37 | 36 | 41 | PER, x | 57.3 | 51.7 | 46.5 | 46.9 | 41.9 | EV/EBIDTA, x | 44 | 39 | 34 | 34 | 29 | P/BV, x | 60 | 53 | 47 | 38 | 35 | ROE, % | 105 | 103 | 101 | 80 | 84 | Total debt/Equity (%) | -102.9 | -71.2 | -87.6 | -46.9 | -31.9 |
|
|
Latest Reports
|
Date |
Description |
Country |
Analyst |
Download |
|
26-Oct-2023 |
Colgate Palmolive (CLGT IN) 2QFY24 Result Update: Prioritizing profits over market development ; Maintain SELL with TP of Rs. 1,550/ |
India |
Vishal Gutka |
|
13-May-2023 |
Colgate Palmolive (CLGT IN) 4QFY23 Result Update: Execution important for re-rating ; Maintain SELL with TP of Rs. 1,375/- |
India |
Vishal Gutka |
|
25-Jan-2023 |
Colgate Palmolive (CLGT IN) 3QFY23 Result Update: Elongated road to recovery ; Maintain SELL with Revised TP of Rs. 1,225 |
India |
Vishal Gutka |
|
24-Jan-2023 |
Colgate Palmolive (CLGT IN) 3QFY23 Result Update: Elongated road to recovery ; Maintain SELL with Revised TP of Rs. 1,225/ |
India |
Vishal Gutka |
|
13-Dec-2022 |
Colgate Palmolive (CLGT IN): Analyst Meet - Same Paste, New Dispenser ; Maintain SELL with Revised TP of Rs. 1,265 |
India |
Vishal Gutka |
|
20-Oct-2022 |
Colgate Palmolive (CLGT IN) 2QF23: Quarterly Update - Cut down in ad spends drives beat in earnings ; Maintain High Conviction SELL with TP of Rs. 1,200 |
India |
Vishal Gutka |
|
27-Jul-2022 |
Colgate Palmolive (CLGT IN) 1QFY23 Result Update: Gross margin pressure finally starts weighing on profitability ; Maintain SELL with revised TP of Rs. 1,250 |
India |
Vishal Gutka |
|
26-May-2022 |
Colgate Palmolive (CLGT IN) 4QFY22 Result Update: Better than expected gross margin drive the beat ; Maintain SELL with TP of Rs. 1,300/ |
India |
Vishal Gutka |
|
27-Jan-2022 |
Colgate Palmolive (CLGT IN): Who moved my smile? ; Maintain SELL with TP of Rs. 1,225 |
India |
Vishal Gutka |
|
03-Nov-2021 |
Colgate Palmolive (CLGT IN)- Company update: Is there light at the end of the tunnel? ; Maintain SELL with TP of Rs. 1,350 |
India |
Vishal Gutka |
|
25-Oct-2021 |
Colgate Palmolive: 2QFY22 (PhillipCapital India) - Struggling to retain the market share; Maintain SELL with TP of Rs. 1,350 |
India |
Vishal Gutka |
|
03-Aug-2021 |
Colgate Palmolive - Company Update: Who moved my smile?; Maintain SELL with TP - Rs. 1400 |
India |
Vishal Gutka |
|
17-May-2021 |
Colgate Palmolive Q4FY21: Focus on margin over market share continues. Maintain SELL |
India |
Vishal Gutka |
|
29-Jan-2021 |
Colgate Palmolive :Company Update: Market loss saga continues for another quarter: Maintain-SELL |
India |
Vishal Gutka |
|
28-Jan-2021 |
Colgate Palmolive 3QFY21: Nothing much to gung-ho about : Maintain-SELL |
India |
Vishal Gutka |
|
18-Dec-2020 |
Colgate Palmolive: Company Update:Interesting innovations, but not enough to move the needle - Maintain SELL |
India |
Vishal Gutka |
|
04-Nov-2020 |
Colgate Palmolive: Company Update: Losing its smile - Maintain SELL |
India |
Vishal Gutka |
|
21-Oct-2020 |
Colgate Palmolive Q2FY21: Benign input costs and reduction in ad spends drives bea |
India |
Vishal Gutka |
|
21-Oct-2020 |
Colgate Palmolive Q2FY21: Benign input costs and reduction in ad spends drives bea |
India |
Vishal Gutka |
|
29-Jul-2020 |
Colgate Palmolive Q1FY21: Smiling back again? |
India |
Vishal Gutka |
|
22-May-2020 |
Colgate Palmolive: Company Update - More hope, less delivery |
India |
Vishal Gutka |
|
30-Jan-2020 |
Colgate Palmolive Q3FY20: More hope, less delivery |
India |
Vishal Gutka |
|
24-Oct-2019 |
Colgate Q2FY20: More hope, less delivery; Maintain Sell |
India |
Vishal Gutka |
|
18-Jul-2019 |
Colgate :Losing its smile ; Downgrade to Sell |
India |
Vishal Gutka |
|
28-May-2019 |
Colgate : Elongated road to recovery ; Downgrade to Neutral |
India |
Vishal Gutka |
|
|
|
|
|
|
|
|